Nasal Drug Delivery Market to Witness Healthy Growth in Coming Years
Increasing prevalence of
various respiratory disorders and demand for non-invasive techniques to drive
global nasal drug delivery market
According
to TechSci Research report, “Global
Nasal
Drug Delivery Market By Drug Type (Anesthetics, Antibiotics, Pain Relief
Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, Others), By Dosage
Form (Drops, Sprays, Powder, Gels & Ointments), By Container Type
(Non-pressurized Containers, Pressurized Containers), By Basis of System (Unit Dose,
Multi-Dose, Metered Dose), By Delivery Technologies (Spray, Nebulizers,
Inhalers, Others), By Therapeutic Applications (Rhinitis, Asthma, Nasal
Congestion, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis,
Others), By End User (Home Care Settings, Hospitals & Clinics), By Distribution
Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), By Region,
Forecast & Opportunities, 2025”, the market is predicted to grow at a significant CAGR
during the forecast period. The global nasal drug delivery market is primarily
driven by increasing prevalence of various respiratory disorders such as
asthma, Chronic Obstructive Pulmonary Disease (COPD) and pneumonia around the globe
coupled with growing patient preference for nasal products. The efficacy and easy
administration properties of nasal drug delivery devices is creating their high
demand in global market. Moreover, development of new and advanced nasal drug
delivery devices and increasing awareness among patients about the benefits of
these products is expected to propel the market growth through 2025. Also, the
growing demand for non-invasive techniques and less painful treatments are
creating profitable opportunity for nasal drug delivery device manufacturers.
Additionally, nasal drug delivery devices provide self-medication,
which does not require visit to the doctor and makes it easy for the patients
to stay and medicate at home. Thus, with increasing demand for home healthcare
devices and growing adoption of self-administration practices, global nasal
drug delivery market is expected to witness substantial growth during the
forecast period.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on"Global Nasal Drug Delivery Market"
https://www.techsciresearch.com/report/nasal-drug-delivery-market/5174.html
The global
nasal drug delivery market is segmented based on drug type, dosage form,
container type, basis of system, delivery technologies, therapeutic
applications, end user, distribution channel and region. Based on dosage form,
the market can be segmented into drops, sprays, powder, gels & ointments.
Among them, sprays segment contributed to highest revenue growth in 2019 owing
to growing rising cases of infections and allergic rhinitis, leading to high
demand for generic forms of spray drugs. However, the drops segment is
anticipated to undergo fastest CAGR during the forecast period as they are
affordable, and their treatment success rates is high compared to other dosage
forms.
Major players operating in the global nasal
drug delivery market include GlaxoSmithKline Plc., Pfizer, Inc., AstraZeneca
PLC, Novartis AG, Becton Dickson & Company, Promius Pharma LLC, 3M COMPANY,
Johnson & Johnson Services, Inc., Sanofi S.A., Merck & Co., Inc.,
Cadila Pharmaceuticals , Aegis Therapeutics, LLC, B.F. Ascher & Company,
Inc., ENT Technologies Pty. Ltd. and AptarGroup, Inc. Leading companies are
focusing on new product development, and are undergoing joint ventures to
increase their share in global nasal drug delivery market.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5174
Customers
can also request for 10% free customization on this report.
“The
presence of major manufacturers and increasing cases of respiratory disorders
in countries like United States and Canada are making North America a lucrative
market for nasal drug delivery. The region is further expected to dominate
through 2025 owing to advancements in healthcare and launch of new technology
equipped nasal drug delivery devices. However, Asia Pacific is anticipated to
witness fastest CAGR during the forecast period due to increasing patient pool
suffering from chronic and respiratory disorders and increasing per capita
disposable income,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Global Nasal Drug Delivery Market By Drug Type
(Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements,
Vasoconstrictors, Antihistamines, Others), By Dosage Form (Drops, Sprays,
Powder, Gels & Ointments), By Container Type (Non-pressurized Containers,
Pressurized Containers), By Basis of System (Unit Dose, Multi-Dose, Metered
Dose), By Delivery Technologies (Spray, Nebulizers, Inhalers, Others), By Therapeutic
Applications (Rhinitis, Asthma, Nasal Congestion, Chronic Obstructive Pulmonary
Disease (COPD), Cystic Fibrosis, Others), By End User (Home Care Settings,
Hospitals & Clinics), By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global nasal
drug delivery market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global nasal drug delivery market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]